While an extreme situation – such as the current COVID-19 pandemic – can uncover weaknesses we weren’t aware of in some companies, it also serves to further highlight problems that existed before.
Investor Intelligence: Weekly Wrapups
Trulieve beats estimates, iAnthus defaults on debt, Harvest in multiple lawsuits & KushCo’s massive reserve for losses
The latest round of cannabis earnings highlight the potential long-term impacts of current conditions, driven by back-to-back crises and other events.
MedMen and Green Growth restructure, Acreage pulls guidance & Canntrust trading halts
It was a week of reckoning for many in the cannabis industry as the coronavirus outbreak has become the straw that broke the cash-challenged camel’s back – or the material adverse change companies are using to change plans made in different times.
Harvest terminates one deal and closes another, KushCo reorganizes for positive EBITDA, Curaleaf buys 3 dispensaries & more
Harvest Health terminates Verano acquisition, buys Franklin Labs It was a busy week for Harvest Health & Recreation (CSE: HARV), terminating its planned acquisition of Illinois-based Verano Holdings on Thursday and then announcing plans on Friday to acquire Franklin Labs. We offered a detailed analysis of the proposed Verano acquisition, which you can read here, […]
Sales surge on coronavirus, Acreage delays funding & Cronos restates 40% of sales
This week, we saw our investment these play out: Companies with solid fundamental operations strategy will continue to be good investments even as public markets make wild swings.
What to do in this bear market, new Florida market analysis, KushCo retracts guidance and more
Cannabis stocks aren’t immune from the wild swings of the broader public markets, but even in this bear market, we maintain our investment thesis for the industry.
Canopy cuts capacity, CURA heats up Colorado, Linton launches hemp SPAC & Caltabiano quits Cresco
Cannabis companies – both marijuana and hemp – were heating up the headlines this week. From Canada to Colorado and beyond, execs made big announcements and companies shifted gears.
MedMen reports bleak quarter, Green Growth to sell CBD business & Medicine Man founder is leaving
MMEN reports a ‘grim’ quarter and difficult outlook MedMen (CSE: MMEN) reported its fiscal second-quarter 2020 financials, and the results – as well as the forward outlook for the company – are “grim.” The company needs to achieve an incredibly difficult task: Drive massive revenue growth while significantly restructuring its operations and making deep, structural […]
Read More
MDCL unveils team + upcoming plans, secured real estate loans versus sale-leasebacks & debunking bombastic claims
We take a closer look at some of the key events from the past week, including news from Medicine Man Technologies, SOL Global and Acreage Holdings.
Read More
Aurora’s tough road ahead, Canopy’s new priorities, Trulieve’s Florida market share & Neptune’s US hemp product launch
The cannabis industry continues its march toward maturity – something reflected in how companies have responded to the latest round of earnings results from the industry.
Read More
New execs for Aurora and Curaleaf, Acreage announces debt financing & Trulieve takes a hit in Florida
Another busy week in cannabis, with more executive changes and new financings as the cannabis industry continues to deal with unfunded cash burn.
Read More
Biermen out as MedMen CEO, Flowr makes sweeping management changes & TerrAscend gets interim CEO
Abrupt senior management changes are yellow flags that warrant further investigation by current and prospective investors. This week’s headlines offered many opportunities for such review.
Read More